Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
---|
Total Revenue
|
108,807,000
|
115,173,000
|
115,706,000
|
127,363,000
| Cost of Revenue | 69,635,000 | 73,556,000 | 74,308,000 | 76,131,000 | |
Gross Profit
|
39,172,000
|
41,617,000
|
41,398,000
|
51,232,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | 18,555,000 | 19,244,000 | 19,488,000 | 20,720,000 |
|
Non Recurring | 445,000 | 452,000 | 494,000 | 372,000 |
|
Others | 4,110,000 | 4,110,000 | 4,037,000 | 3,899,000 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
16,062,000
|
17,811,000
|
17,379,000
|
26,241,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 16,062,000 | 17,811,000 | 17,379,000 | 26,241,000 |
|
Interest Expense | 24,000 | 111,000 | 59,000 | 50,000 |
|
Income Before Tax | 16,038,000 | 17,700,000 | 17,320,000 | 26,191,000 |
|
Income Tax Expense | 6,277,000 | 7,398,000 | 7,394,000 | 8,537,000 |
|
Minority Interest | (261,000) | (352,000) | (356,000) | (1,744,000) |
|
|
|
Net Income From Continuing Ops | 9,500,000 | 9,950,000 | 9,570,000 | 15,910,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
9,500,000
|
9,950,000
|
9,570,000
|
15,910,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
9,500,000
|
9,950,000
|
9,570,000
|
15,910,000
|
|